Diagnosis of leishmaniasis

Clinics in Dermatology

Volumn 14, Issue 5, 1996, Pages 471-478

  Reed, Steven G ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EXAMINATION; HUMAN; INTRACUTANEOUS TEST; LEISHMANIA DONOVANI; LEISHMANIA TROPICA; LEISHMANIASIS; PARASITE IDENTIFICATION; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

EID: 0030249401     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00038-7     Document Type: Article

References (42)

1. 1. Manson-Bahr PEC. Diagnosis. In: Peters W, Killick-Kendrick R, editors. The leishmaniases in biology and medicine, Clinical aspects and control. New York: Academic Press, 1987:703-29.
2. 2. Barker DC, Butcher J. The use of DNA probes in the identification of leishmaniasis: discrimination between isolates of Leishmania mexicana and L. braziliensis complexes. Trans R Soc Trop Med Hyg 1983;77:285-97.
3. 3. Howard KM, Kelley JM, Lane RP, et al. A sensitive repetitive DNA probe that is specific to the Leishmania donovani complex and its use as an epidemiological and diagnostic reagent. Mol Biochem Parasitol 1991;44:63-72.
4. 4. Lynch NR, Malave' C, Ifante RB, et al. In situ detection of amastigotes in American cutaneous leishmaniasis using monoclonal antibodies. Trans R Soc Trop Med Hyg 1986; 80:6-9.
5. 5. Smyth AJ, Ghosh A, Hassan MQ, et al. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients. Parasitology 1992;105:183-92.
6. 6. Piarroux R, Gambarelli F, Dumon H, et al. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients. J Clin Microbiol 1994;32:746-9.
7. 7. Rodrizues N, Guzman B, Rodas A, et al. Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J Clin Microbiol 1994; 32:2246-52.
8. 8. Mathis A, Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J Clin Microbiol 1995;33:1145-9.
9. 9. Ashford DA, Bozza M, Freire M, et al. Comparison of the polymerase chain reaction and serology for the detection of canine visceral leishmaniasis. Am J Trop Med Hyg 1995;53:251-5.
10. 10. Walton BC, Brooks WH, Arjona I. Serodiagnosis of American leishmaniasis by indirect fluorescent antibody test. Am J Trop Med Hyg 1972;21:296-9.
11. 11. Laty BMA, Al-Senawi FA, Al-Alousi TI. The indirect fluorescent antibody test for diagnosis of kala-azar infection in Iraq. Ann Trop Med Parasitol 1979;73:31-5.
12. 12. Edissian GH, Darabian P. A comparison of enzyme-linked immunosorbant assay and indirect fluorescent antibody test in the serodiagnosis of cutaneous and visceral leishmaniasis in Iran. Trans R Soc Trop Med Hyg 1979;73: 289-92.
13. 13. Dye C, Vidor E, Dereure J. Serological diagnosis of leishmaniasis on detecting infection as well as disease. Epidemiol Infect 1993;110:647-56.
14. 14. Allain DS, Kagan IG. A direct agglutination test for leishmaniasis. Am J Trop Med Hyg 1975;24:232-6.
15. 15. Harith AE, Kolk AHJ, Kager PA, et al. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1986;80:583-7.
16. 16. Hommel M, Peters W, Rangue J, et al. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol 1978;72:213-8.
17. 17. Ho M, Leeuwenburg J, Mbugua G, et al. An enzyme-linked immunosorbant assay (ELISA) for field diagnosis of visceral leishmaniasis. Am J Trop Med Hyg 1983;32: 943-6.
18. 18. Jahn A, Diesfeld HJ. Evaluation of a visually read ELISA for serodiagnosis and seroepidemiological studies of kalaazar in the Baringo District, Kenya. Trans R Soc Trop Med Hyg 1983;77:451-4.
19. 19. Badaro R, Reed SG, Barral A, et al. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: Antigen selection for detection of infection-specific responses. Am J Trop Med Hyg 1986;35:72-8.
20. 20. Reed SG, Shreffler WG, Burns JM, et al. An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg 1990;43:632-9.
21. 21. Ashford DA, Badaro R, Eulalio C, et al. Studies on the control of visceral leishmaniasis. Validation of the Falcon Assay Screening Test-Enzyme-Linked Immunosorbant Assay (FAST-ELISA™) for field diagnosis of canine visceral leishmaniasis. Am J Trop Med Hyg 1993;48:1-8.
22. 22. Badaro R, Benson DR, Eulalio MC, et al. rK39: A cloned antigen of Leishmania chagasi that both detects and predicts active visceral leishmaniasis. J Infect Dis (in press).
23. 23. Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986;154:1003-11.
24. 24. Burns JM, Shreffler WG, Benson DR, et al. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in both African and American visceral leishmaniasis. Proc Natl Acad Sci USA 1993;90:775-9.
25. 25. Singh S, Gilman-Sachs A, Chang KP, et al. Diagnostic and prognostic value of rK39 antigen in Indian leishmaniasis. J Parasitol (in press).
26. 26. Mebrahtu Y, Lawyer P, Githure J, et al. Visceral leishmaniasis unresponsive to pentostam caused by Leishmania tropica in Kenya. Am J Trop Med Hyg 1989;41:289-94.
27. 27. Oren R, Schnur LF, Yehuda DB, et al. Visceral leishmaniasis: A difficult diagnosis and unusual causative agent. J Infect Dis 1991;164:746-9.
28. 28. Magill AJ, Grogl M, Gasser RA, et al. Visceral infection caused by Leishmania tropica in veterans of operation Desert Storm. N Engl J Med 1993;328:1383-7.
29. 29. Dillon DC, Day CH, Whittle JA, et al. Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients. Proc Natl Acad Sci USA 1995;92:7981-5.
30. 30. Reed SG, Carvalho EM, Sherbert CH, et al. In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis and Chagas' disease. J Clin Invest 1990;85:690-6.
31. 31. Russo DM, Burns JM, Jr, Carvalho EM, et al. Human T cell responses to gp63, a surface antigen of Leishmania. J Immunol 1991;147:3575-80.
32. 32. Russo DM, Jardim A, Carvalho EM, et al. Mapping human T cell epitopes in Leishmania gp63; Identification of cross-reactive and species-specific epitopes. J Immunol 1993;150:932-9.
33. 33. Skeiky YAW, Guderian JA, Benson DR, et al. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin-12. J Exp Med 1995;181: 1527-37.
34. 34. Russo DM, Turco SJ, Burns JM, Jr, et al. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J Immunol 1992;148:202-7.
35. 35. Jaffe CL, Shor R, Trau H, et al. Parasite antigens recognized by patients with cutaneous leishmaniasis. Clin Exp Immunol 1990;80:77-82.
36. 36. Buss G. Untersuchungen mit Leishmania Vakzine. Arch F Schiffs N Trop Hyg 1929;33:65-72.
37. 37. Reed SG, Badaro R, Masur H, et al. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 1985;35:79-85.
38. 38. Wagner EH. A skin reaction to extracts of Leishmania infantum. Univ Calif Publ Zool 1923;20:473-88.
39. 39. Montenegro J. A cutis-reaccao na leishmaniose. Ann Fac Med Univ Sao Paulo 1926;1:323-30.
40. 40. Alimohammadian MH, Kivanjah M, Pak F, et al. Evaluation of efficacy of Iran leishmanin and comparison with leishmanin from Wellcome (U.K.) and Roma, Italy in cured cutaneous leishmaniasis patients. Trans R Soc Trop Med Hyg 1993;87:550-1.
41. 41. Badaro R, Pedral-Sampaio D, Johnson WD Jr, et al. Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis. Trans R Soc Trop Med Hyg 1990;84:226-7.
42. 42. Abramson MA, Dietze R, Frucht DM, et al. Comparison of New and Old World leishmanins in an endemic region of Brazil. Clin Infect Dis 1995;20:1292-7.